Log in to save to my catalogue

Therapeutic adenine base editing of human hematopoietic stem cells

Therapeutic adenine base editing of human hematopoietic stem cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4f2094ecf5e4ebe9d711d75133738a7

Therapeutic adenine base editing of human hematopoietic stem cells

About this item

Full title

Therapeutic adenine base editing of human hematopoietic stem cells

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-01, Vol.14 (1), p.207-11, Article 207

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In β-thalassemia, either γ-globin induction to form fetal hemoglobin (α2γ2) or β-globin repair to restore adult hemoglobin (α2β2) could be therapeutic. ABE8e, a recently evolved adenine base editor variant, can achieve efficient adenine conversion, yet its application in patient-derived hematopoietic stem cells needs further exploration. Here, we p...

Alternative Titles

Full title

Therapeutic adenine base editing of human hematopoietic stem cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d4f2094ecf5e4ebe9d711d75133738a7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4f2094ecf5e4ebe9d711d75133738a7

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-35508-7

How to access this item